Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Chemical Structure: Synthetic 39 amino acid triple agonist, Proprietary Complex peptidyl structure with C 20 fatty acid Alternative Names: LY3437943 CAS Number: Not applicable WHAT IS RETATRUTIDE Retatrutide, also known as LY-3437943, is an experimental medication developed by Eli Lilly that is being studied as a next-generation treatment for obesity, overweight, and related metabolic conditions such as type 2 diabetes
Heart Palpitations: Irregular or rapid heartbeats can occur, which can be concerning and require medical attention
Compounded tirzepatide drops to $219 a month on a three-month plan and $199 a month on a six-month plan
Eventually, she explained that she had been suffering from binge eating disorder and depression, and had gone on GLP-1s
Conclusion Compounded GLP-1 therapies are likely to remain part of clinical practice as long as shortages, affordability challenges, and growing patient demand continue
US$ 22.47
US$ 24.91
US$ 21.28
US$ 24.27
